NEW
YORK, Sept. 16, 2022 /PRNewswire/ -- Jakubowitz
Law announces that a securities fraud class action lawsuit has
commenced on behalf of shareholders of Co-Diagnostics, Inc.
(NASDAQ: CODX).
To receive updates on the lawsuit, fill out the
form:
https://claimyourloss.com/securities/co-diagnostics-inc-loss-submission-form-2/?id=31782&from=4
This lawsuit is on behalf of a class of all persons and entities
who purchased the publicly traded securities of Co-Dx during the
period of May 12, 2022 through the
close of the market on August 11,
2022 (4:00 p.m. ET).
Shareholders interested in acting as a lead plaintiff
representing the class of wronged shareholders have until
October 17, 2022 to petition
the court. Your ability to share in any recovery doesn't require
that you serve as a lead plaintiff.
According to a filed complaint, Co-Diagnostics, Inc. issued
materially false and/or misleading statements and/or failed to
disclose that: (i) demand for the Company's Logix Smart™ COVID-19
test had plummeted throughout the quarter ended June 30, 2022, and (ii) as a result, defendants'
positive statements about the demand for its Logix Smart™ COVID-19
test lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/codx-shareholder-alert-jakubowitz-law-reminds-co-dx-shareholders-of-a-lead-plaintiff-deadline-of-october-17-2022-301625743.html
SOURCE Jakubowitz Law